Will taking Depakine affect development in children?
Jun 05, 2023
Source: Cainiu Health
Dr. Zhu Gang
Introduction
Depakine refers to sodium valproate sustained-release tablets. Whether children taking sodium valproate sustained-release tablets will affect development depends on individual circumstances. Short-term use generally does not affect development, whereas long-term use may potentially impact it. Each child is different, and factors such as duration of medication, dosage, age, and individual differences can all influence a child's development.
Generally speaking, Depakine refers to sodium valproate sustained-release tablets. Whether children taking sodium valproate sustained-release tablets will affect their development depends on specific circumstances. If taken for a short period, it usually does not affect development. However, long-term use may impact growth and development. The detailed analysis is as follows:
1. No effect
Short-term use involves a brief duration and lower dosage, thus having relatively minimal impact on children's growth and development. If children receive adequate nutrition and physical activity while taking sodium valproate sustained-release tablets, the negative effects of the medication on growth and development can also be reduced.
2. Possible effect
Sodium valproate sustained-release tablets may reduce insulin secretion, thereby affecting the secretion of growth hormone in children and leading to suppressed growth and development. Long-term use of sodium valproate sustained-release tablets may also cause liver function impairment, which in turn affects children's growth and development.
It should be noted that each child’s situation is different; factors such as duration of medication, dosage, age, and individual differences can all influence a child's development. Therefore, when administering drug treatment to children, specific circumstances must be considered and treatment should be conducted under the guidance of a physician.
